SMI
12.793,74
PKT
+91,66
PKT
+0,72
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.01.22 | Swiss Re Sell | UBS AG | |
| 26.01.22 | UBS Buy | Jefferies & Company Inc. | |
| 26.01.22 | Roche Buy | Deutsche Bank AG | |
| 26.01.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 26.01.22 | Holcim Buy | UBS AG | |
| 26.01.22 | UBS Underweight | Barclays Capital | |
| 25.01.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.01.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 25.01.22 | UBS Sector Perform | RBC Capital Markets | |
| 25.01.22 | UBS Neutral | UBS AG | |
| 24.01.22 | Richemont Outperform | Bernstein Research | |
| 24.01.22 | Zurich Insurance Buy | Kepler Cheuvreux | |
| 24.01.22 | ABB (Asea Brown Boveri) Buy | Kepler Cheuvreux | |
| 24.01.22 | UBS Underweight | Barclays Capital | |
| 24.01.22 | UBS Equal Weight | Barclays Capital | |
| 24.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 24.01.22 | Swiss Re Outperform | Credit Suisse Group | |
| 21.01.22 | Holcim Neutral | JP Morgan Chase & Co. | |
| 21.01.22 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.01.22 | Richemont Buy | Deutsche Bank AG | |
| 21.01.22 | Richemont Overweight | Barclays Capital | |
| 20.01.22 | Richemont Buy | Kepler Cheuvreux | |
| 20.01.22 | Nestlé Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.01.22 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.01.22 | Swiss Re Overweight | Barclays Capital | |
| 20.01.22 | Richemont Neutral | Credit Suisse Group | |
| 20.01.22 | Richemont Buy | UBS AG | |
| 20.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.01.22 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.01.22 | Richemont Buy | Kepler Cheuvreux | |
| 19.01.22 | UBS Buy | Kepler Cheuvreux | |
| 19.01.22 | Givaudan Underweight | Barclays Capital | |
| 19.01.22 | Richemont Buy | UBS AG | |
| 19.01.22 | Richemont Outperform | RBC Capital Markets | |
| 19.01.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 19.01.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.01.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 19.01.22 | Holcim Overweight | Barclays Capital | |
| 18.01.22 | Givaudan Neutral | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.